Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

SPDR S&P Cons Disc Sector International (IPD) AMEX

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.60 +5.26%
on 11/16/16
36.48 -0.16%
on 12/08/16
+1.03 (+2.91%)
since 11/09/16
3-Month
34.60 +5.26%
on 11/16/16
36.96 -1.46%
on 09/22/16
+0.08 (+0.22%)
since 09/09/16
52-Week
31.52 +15.55%
on 06/27/16
37.40 -2.62%
on 04/15/16
-0.84 (-2.25%)
since 12/09/15

Most Recent Stories

More News
Study on Efficacy of L-Dex® in Routine Clinical Practice Published

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status and body composition, today announced that a new study published in the journal Frontiers...

SOZO(TM) Launched - First Product for Health and Wellness Markets

ImpediMed Limited (ASX: IPD) announced today that SOZO(TM), the first product on its new population health platform that allows consumers and patients to measure and track their body composition, fluid...

Scripps to use SOZO in Heart Failure Study

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status and body composition, today announced that Scripps Health will use the SOZOTM device in...

FDA Releases Important Information Focused on Digital Health

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status and body composition, today announced that the U.S. Food and Drug Administration (FDA)...

ImpediMed Changes to Board of Directors

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status and body composition, today announced several changes to its Board of Directors.

ImpediMed Presents at Bioshares Biotech Summit 2016

ImpediMed Limited (ASX: IPD) a global provider of medical technology to measure, monitor and manage fluid status and body composition, announced that Managing Director and CEO, Richard Carreon, presented...

ImpediMed and Mayo Clinic Sign Joint Development Agreement

ImpediMed Limited (ASX: IPD) announced today that it has entered into a three-year joint development agreement with Mayo Clinic to advance new solutions for its fluid status and body composition monitoring...

ImpediMed Establishes Medical Advisory Board for Chronic Heart Failure

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status and body composition, announced today that it has entered into agreements to establish...

ImpediMed Announces U.S. Commercial Launch of L-Dex® System for Assessment of Lymphedema in Cancer Survivors

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status in patients, has announced the U.S. commercial launch of its L-Dex® system to aid in the...

Forget PBS, Buy These Consumer Discretionary ETFs Instead - ETF News And Commentary

Media stocks recently witnessed a horrendous sell-off. Investors thus can ignore media ETF PBS and consider these consumer discretionary ETFs instead.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Fund Summary

The SPDR S&P International Consumer Discretionary Sector ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Developed Ex-U.S. BMI Consumer Discretionary Sector Index. The Index is designed to represent the non-U.S. consumer...

See More

Support & Resistance

2nd Resistance Point 36.55
1st Resistance Point 36.49
Last Price 36.42
1st Support Level 36.29
2nd Support Level 36.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.